October 05 – Cancer Therapeutics CRC Pty Ltd, Melbourne, Australia (CTx) today announced a collaboration with Duke University, North Carolina, USA (Duke) to discover and develop new

October 13 – Merck KGaA announced today the acquisition of Bangalore Genei (India) Private Ltd. (BGIP) by its wholly owned subsidiary in India, Merck Specialities Private Ltd., from the Sanmar

September 30 – Genzyme, one of the world’s foremost biotechnology companies, today announced a tie-up with NIPER (National Institute of Pharmaceutical Education and Research) under

September 22 – QIAGEN N.V. (NASDAQ: QGEN) today announced that it has acquired DxS Ltd (DxS), a privately-held developer

September 22 – AstraZeneca and Nektar Therapeutics (Nasdaq:NKTR) announced today that they have entered into an exclusive worldwide license agreement for two drug development programmes: NKTR-118,

September 17- QIAGEN (NASDAQ: QGEN), today announced that it has acquired additional licenses from Roche and Idaho Technology related to the use of instrumentation and reagents for PCR-based

June 4 – Cegedim Dendrite, global leader in Customer Relationship Management for the life sciences industry, announces a 3 year agreement with leading

May 27 – The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services and assisted living companies, announced today that it has completed the purchase of an 83-bed skilled nursing facility in Draper, Utah for approximately $3.0 million

Sept. 17 — United BioSource Corporation (UBC) today announced the acquisition of Caro Research, Inc., a leading provider of simulation technologies that help pharmaceutical and life

September 29 –Ambion, Inc., an Austin-based life sciences company that develops technologies for RNA analysis, and GE Healthcare, a unit of General Electric Company